Independent, AI-assisted research · Affiliate disclosure
HBOT Finder

HBOT by Condition

Hyperbaric oxygen therapy is approved for a specific list of conditions and marketed for many more. We separate the two. Below are the 15 UHMS-approved indications — backed by the Undersea & Hyperbaric Medical Society and generally insurance-covered — from the off-label and wellness uses that are not approved. Each page lists typical treatment pressure, session counts, and which centers in our directory are equipped.

Why the distinction matters: approved indications are typically delivered in clinical hard-shell chambers at 2.0–3.0 ATA. Many off-label wellness uses run in mild soft-shell chambers near 1.3 ATA — a different treatment entirely. Always confirm chamber type and pressure.

FDA / UHMS-Approved Indications

The 15 conditions with established hyperbaric medicine evidence and society approval.

UHMS-approved

Carbon Monoxide Poisoning

An emergency UHMS-approved indication. Hyperbaric oxygen rapidly clears carbon monoxide from the blood and may reduce delayed neurological injury.

2.5–3.0 ATA1–3 sessions (emergent)
UHMS-approved

Decompression Sickness

The classic diving injury ("the bends"). Recompression with hyperbaric oxygen is the definitive UHMS-approved treatment.

2.8 ATA (US Navy Treatment Table 6)1+ (per protocol)
UHMS-approved

Arterial Gas Embolism

Gas bubbles in the arterial circulation — from diving, surgery, or vascular procedures. A UHMS-approved hyperbaric emergency.

2.8–6.0 ATA (Treatment Table 6/6A)1+ (emergent)
UHMS-approved

Diabetic Foot Ulcers & Problem Wounds

Under the UHMS "enhancement of healing in selected problem wounds" indication, HBOT is an adjunct for qualifying Wagner grade 3+ diabetic foot ulcers.

2.0–2.5 ATA20–40 sessions
UHMS-approved

Delayed Radiation Injury

Soft-tissue and bony injury that surfaces months to years after cancer radiotherapy (e.g. osteoradionecrosis, radiation cystitis, proctitis). A UHMS-approved indication.

2.0–2.4 ATA30–40 sessions
UHMS-approved

Refractory Osteomyelitis

Chronic bone infection that persists despite antibiotics and surgery. HBOT is a UHMS-approved adjunct.

2.0–2.4 ATA20–40 sessions
UHMS-approved

Necrotizing Soft Tissue Infections

Rapidly spreading, life-threatening infections such as necrotizing fasciitis and Fournier's gangrene. A UHMS-approved adjunct.

2.0–3.0 ATAPer clinical course (often BID early)
UHMS-approved

Clostridial Myonecrosis (Gas Gangrene)

A fulminant clostridial muscle infection. HBOT is a UHMS-approved adjunct that can be lifesaving when started early.

3.0 ATAMultiple over the first days
UHMS-approved

Crush Injury & Acute Traumatic Ischemia

Severe crush injuries, compartment syndrome, and other acute traumatic ischemias. A UHMS-approved adjunct in the first days after injury.

2.0–2.5 ATA~12 sessions over the first days
UHMS-approved

Compromised Grafts & Flaps

Skin grafts and surgical flaps at risk of failure from poor perfusion. A UHMS-approved indication to support tissue survival.

2.0–2.4 ATA~20 sessions
UHMS-approved

Acute Thermal Burn Injury

Serious thermal burns. HBOT is a UHMS-approved adjunct at specialized burn centers.

2.0–2.4 ATAPer burn-center protocol
UHMS-approved

Central Retinal Artery Occlusion

A sudden, painless loss of vision from blockage of the retina's main artery. A time-critical UHMS-approved indication.

2.0–2.8 ATAUntil stabilized, then tapered
UHMS-approved

Idiopathic Sudden Sensorineural Hearing Loss

Abrupt, unexplained hearing loss in one ear. The newest UHMS-approved indication, used with or after steroid therapy.

2.0–2.5 ATA10–20 sessions
UHMS-approved

Intracranial Abscess

Pus-filled infection within the skull. HBOT is a UHMS-approved adjunct, particularly for multiple or deep abscesses.

2.0–2.5 ATAPer neurosurgical course
UHMS-approved

Exceptional Blood-Loss Anemia

Severe anemia when transfusion is impossible (e.g. patient refusal or incompatibility). A UHMS-approved bridge therapy.

2.0–3.0 ATAAs needed to bridge

Off-Label & Wellness Uses

Commonly marketed, but not FDA/UHMS-approved. Evidence ranges from preliminary to mixed, and these are rarely insurance-covered.

This information is educational and not medical advice. Hyperbaric oxygen therapy decisions should be made with a qualified physician. Approved-indication status follows the Undersea & Hyperbaric Medical Society Committee Report.